Results 281 to 290 of about 131,254 (306)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Boll, Peter Schellongowski   +2 more
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul H Parikh, Sagar Lonial
exaly  

Chimeric Antigen Receptors

RCSB Protein Data Bank, 2017
openaire   +1 more source

Chimeric Antigen Receptor T-Cell Therapy–Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma

Circulation, 2020
Sarju Ganatra, Robert A Redd, Salim S Hayek   +2 more
exaly  

Chimeric Antigen Receptor T Cells in Myeloma

New England Journal of Medicine, 2016
Alfred L, Garfall, Edward A, Stadtmauer, Carl H, June   +2 more
openaire   +3 more sources

Chimeric Antigen Receptor Therapies

2020
Lisa Senzel, Tahmeena Ahmed, Yupo Ma
openaire   +1 more source

Chimeric antigen receptor T cells for ALL

The Lancet, 2015
Persis J, Amrolia, Martin, Pule
openaire   +2 more sources

THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells

Cancer Cell, 2020
Chuang Sun, Peishun Shou, Hongwei Du
exaly  

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies

Cell Transplantation, 2021
Feng Zhu, Guoqing Wei, Wenjun Wu
exaly  

Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase

Molecular Therapy, 2017
Robbie G Majzner, Kelsey M Wanhainen, Adrienne H Long   +2 more
exaly